+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biodesix Inc - Product Pipeline Analysis, 2020 Update

  • ID: 4239708
  • Company Profile
  • June 2020
  • 34 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Cardiocom LLC
  • CardioDx Inc
  • Foundation Medicine Inc
  • Roka Bioscience Inc
  • MORE
Summary

Biodesix Inc (Biodesix) is a molecular diagnostics company which discovers, develops and commercializes multivariate protein and genomic diagnostic blood tests in oncology for patients and doctors to enable precision medicine. These tests are used for early detection of diseases, diagnosis accuracy, disease monitoring and also provide improved therapeutic guidance for cancer patients. Biodesix’s product portfolio includes GeneStrat, a gene panel of clinically actionable mutations for tumor profiling for patients with advanced lung cancer; and VeriStrat, a serum proteomic test for patients with non-small cell lung cancer. The company collaborates with leading researchers to develop companion diagnostics for use with therapeutic agents and work in partnership with biotechnology and pharmaceutical companies such as Aveo Oncology and Biognosys. Biodesix is headquartered in Boulder, Colorado, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Biodesix Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Cardiocom LLC
  • CardioDx Inc
  • Foundation Medicine Inc
  • Roka Bioscience Inc
  • MORE
Biodesix Inc Company Overview
  • Biodesix Inc Company Snapshot
  • Biodesix Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Biodesix Inc – Pipeline Analysis Overview
  • Biodesix Inc - Key Facts
  • Biodesix Inc - Major Products and Services
  • Biodesix Inc Pipeline Products by Development Stage
  • Biodesix Inc Ongoing Clinical Trials by Trial Status
Biodesix Inc Pipeline Products Overview
52-Gene Panel Based Companion Diagnostic
52-Gene Panel Based Companion Diagnostic Product Overview
  • Companion Diagnostic Test - NSCLC
  • Companion Diagnostic Test - NSCLC Product Overview
  • Droplet Digital PCR Test - COVID-19
  • Droplet Digital PCR Test - COVID-19 Product Overview
  • HRM-MS Based Companion Diagnostic Test
  • HRM-MS Based Companion Diagnostic Test Product Overview
  • Nodify XL2
  • Product Status
  • PD-L1 Blood Based Diagnostic Test
  • PD-L1 Blood Based Diagnostic Test Product Overview
  • PD-L1 Blood Based Diagnostic Test Clinical Trial
  • TAm-Seq NGS Lung Cancer Test
  • TAm-Seq NGS Lung Cancer Test Product Overview
  • VeriStrat - Breast Cancer
  • VeriStrat - Breast Cancer Product Overview
  • VeriStrat - Colorectal Cancer
  • VeriStrat - Colorectal Cancer Product Overview
  • Biodesix Inc - Key Competitors
  • Biodesix Inc - Key Employees
  • Biodesix Inc - Locations And Subsidiaries
  • Head Office
Recent Developments
  • Biodesix Inc, Recent Developments
  • Jan 30, 2020: Biodesix, Streck sign agreement to secure FDA approval for products
  • Nov 05, 2019: Biodesix appoints Scott Hutton as chief executive officer
  • Nov 04, 2019: Biodesix announces first system-wide integration of Nodify XL2 Testing for Lung Nodule Management
  • Oct 08, 2019: Biodesix names Dr. James Jett Chief Medical Officer
  • Oct 03, 2019: Biodesix secures U.S. Patent for proprietary blood specimen collection device
  • Sep 23, 2019: Biodesix highlights pipeline and companion diagnostic development at World CDx and RAS-Targeted Drug Discovery
  • Sep 18, 2019: Biodesix announces new clinical data demonstrating VeriStrat testing predicts survival in advanced NSCLC and Immunotherapy
  • Aug 13, 2019: Biodesix adds Dr. Robert Georgantas III to Executive Leadership Team
  • Aug 07, 2019: Biodesix adds Dr. Charles Watts to Board of Directors
  • Jul 09, 2019: Biodesix reaches agreement to deliver next-generation sequencing assay for blood-based companion diagnostic solutions in cancer
Appendix
  • Methodology
  • About the Publisher
  • Contact
  • Disclaimer
List of Tables
  • Biodesix Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Biodesix Inc Pipeline Products by Equipment Type
  • Biodesix Inc Pipeline Products by Indication
  • Biodesix Inc Ongoing Clinical Trials by Trial Status
  • Biodesix Inc, Key Facts
  • Biodesix Inc, Major Products and Services
  • Biodesix Inc Number of Pipeline Products by Development Stage
  • Biodesix Inc Pipeline Products Summary by Development Stage
  • Biodesix Inc Ongoing Clinical Trials by Trial Status
  • Biodesix Inc Ongoing Clinical Trials Summary
52-Gene Panel Based Companion Diagnostic - Product Status
52-Gene Panel Based Companion Diagnostic - Product Description
  • Companion Diagnostic Test - NSCLC - Product Status
  • Companion Diagnostic Test - NSCLC - Product Description
  • Droplet Digital PCR Test - COVID-19 - Product Status
  • Droplet Digital PCR Test - COVID-19 - Product Description
  • HRM-MS Based Companion Diagnostic Test - Product Status
  • HRM-MS Based Companion Diagnostic Test - Product Description
  • Product Status
  • Nodify XL2 - Product Description
  • PD-L1 Blood Based Diagnostic Test - Product Status
  • PD-L1 Blood Based Diagnostic Test - Product Description
  • PD-L1 Blood Based Diagnostic Test - Concordance of Immunohistochemistry and a New Blood-based Expression Assay for the Detection of PD-L1 in Patients Diagnosed with Non-small Cell Lung Cancer
  • TAm-Seq NGS Lung Cancer Test - Product Status
  • TAm-Seq NGS Lung Cancer Test - Product Description
  • VeriStrat - Breast Cancer - Product Status
  • VeriStrat - Breast Cancer - Product Description
  • VeriStrat - Colorectal Cancer - Product Status
  • VeriStrat - Colorectal Cancer - Product Description
  • Biodesix Inc, Key Employees
  • Glossary
List of Figures
  • Biodesix Inc Pipeline Products by Equipment Type
  • Biodesix Inc Pipeline Products by Development Stage
  • Biodesix Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 3
  • CardioDx Inc
  • Roka Bioscience Inc
  • Foundation Medicine Inc
  • Cardiocom LLC
Note: Product cover images may vary from those shown
Adroll
adroll